Company Filing History:
Years Active: 2001
Title: Oliver Bezencon: Innovator in Anti-Viral Agents
Introduction
Oliver Bezencon is a notable inventor based in Kista, Sweden. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-viral agents. His work is characterized by a focus on innovative compounds that can potentially combat viral infections.
Latest Patents
Bezencon holds a patent for "8-hydroxy-7-substituted quinolines as anti-viral agents." This invention provides for 8-hydroxy-7-substituted quinoline compounds, which are designed to serve as effective anti-viral agents. The patent highlights the potential of these compounds in the treatment of viral diseases, showcasing Bezencon's commitment to advancing medical science.
Career Highlights
Oliver Bezencon is associated with Pharmacia & Upjohn Company, where he has been instrumental in research and development. His work has led to advancements in pharmaceutical formulations and therapeutic applications. With a focus on innovation, Bezencon continues to contribute to the field of medicinal chemistry.
Collaborations
Bezencon collaborates with Suvit Thaisrivongs, a fellow researcher, to further explore the potential of his patented compounds. Their partnership exemplifies the collaborative spirit in scientific research, aiming to enhance the efficacy of anti-viral treatments.
Conclusion
Oliver Bezencon's contributions to the field of anti-viral agents through his innovative patent reflect his dedication to improving healthcare solutions. His work at Pharmacia & Upjohn Company and collaboration with fellow researchers underscore the importance of teamwork in scientific advancements.